“Before the mainstream media transfigures Moderna founder and CEO Stephane Bancel into a corporate savior on par with Bill Gates, we’d like to remind investors (and the public) that Moderna and its insiders have demonstrated an eyebrow-raising affinity for pumping the stock with over-hyped press releases then cashing in shares or warrants (all insider stock sales were pre-scheduled divestitures, the insiders’ lawyers have argued).
Despite receiving nearly $1 billion in taxpayer money via “Operation Warp Speed”, the drugmaker is planning to charge as much as $37 for a single dose, or up to $60 for two courses, of its experimental mRNA COVID-19 vaccine. That’s far and away the highest price point disclosed yet.
Now, keep in mind that Moderna is trying to charge as much as $37 per dose for its vaccine, when the vaccine being developed by AstraZeneca and the University of Oxford is priced at about $3 per dose.
Maybe Moderna can make amends for these mistakes by cutting the price its charging the US government for a vaccine that it developed with the help of a massive infusion of government money?”
OVERVIEW OF THE FUNDING OPPORTUNITY Program Announcement for the Department of Defense Health Program Congressionally Directed Medical Research Programs, Peer Reviewed Medical Research Program Clinical Trial Award For Emerging Viral Diseases and Respiratory Health
